3.光束传输和特性

{"title":"3.光束传输和特性","authors":"","doi":"10.1093/jicru_ndy026","DOIUrl":null,"url":null,"abstract":"With the exception of the first ion beam treatments using deuterium and helium beams in 1954 at Berkeley, which were cyclotron-based, only synchrotron-based therapy facilities are in operation today for carbon or other light ion beam therapy. This is due to the significantly higher energies needed to achieve the same range as a proton beam. After the early studies at the Lawrence Berkeley National Laboratory (LBNL) (Castro, 1993), all dedicated particle therapy facilities concentrated primarily on carbon beams for radiotherapy. The layout of a modern synchrotron for carbon ions is also suited to accelerate protons and many therapy facilities do offer proton beams for therapy in addition to carbon ions, which facilitates comparative clinical trials between modalities. Although technically feasible, only the Heidelberg ion beam facility (Haberer et al., 2004) is offering the possibility of providing helium and oxygen ions in addition to protons and carbon ions in all treatment rooms for potential future clinical use. The magnet strength and the fixed diameter of the accelerator ring limit the maximum achievable energy for each ion. A typical synchrotron-based ion facility comprises the following main components: (i) one or several ion sources; (ii) a linac, which acts as a pre-accelerator; (iii) the main synchrotron accelerator to produce high-energy ions; (iv) a beam-transport system to steer the beam to the treatment-delivery system; (v) a treatment-delivery system to adapt the individual treatment fields for each patient. Ion sources use an ionized gas to produce the ions, so that only specific ions can be extracted, using a spectrometer, to select a well-defined charge to mass ratio. The ionized gas is confined by magnetic fields and heated by microwaves, so that a plasma is created. Therefore, separate ion sources are in use for protons, carbon and helium ions, while an oxygen beam can be extracted from the same source as carbon (using carbon dioxide). The beam from different ion sources can be switched quickly to the injection beam line, using a switching magnet. The extraction of a different ion from the same source takes time to tune the source. The ion source is also used to control the beam intensity. The linac injector accelerates ions from several keV/u to the injection energy of the synchrotron, which is typically around 5MeV/u to 10MeV/u. In the main ring, bunches of ions are being injected, accelerated step by step to the desired energy and then extracted to the high-energy beam transport system. This means that the extracted energy can be adapted according to the energy requested by a treatment plan. During acceleration, the magnetic field strength in the ring magnets has to be gradually increased, as well as the frequency of the accelerating radio frequency (RF) cavity. The setting of all the beam elements from the ion source to the high-energy beam line is controlled by an accelerator control system (ACS). The ACS usually can provide predefined sets of ion type, energy, beam diameter, and beam intensity. In the beam delivery system (BDS), the small focused mono-energetic beam is modified, such that a useful treatment field is formed. Moreover, it is monitoring the delivered beam and has control over the delivered RBE-weighted dose to the patient. The BDS may use passive or dynamic techniques and is controlled by the treatment control system (TCS), which also has control over the ACS. The TCS also serves as an interface to the treatmentplanning system. In view of the safety of the patient, the TCS is the most important system in the facility. The BDS may furthermore comprise some or all of the following subsystems: nozzle, monitoring system, beam scanner, gating device, patient positioning and immobilization system. In practice, carbon energies of 400MeV/u (i.e., total kinetic energies of 4.8 GeV) are required to penetrate 25 cm in water (Chu et al., 1993). The higher energy of the extracted ions as compared to a proton therapy beam leads to an increased magnetic rigidity of the beam (Trbojevic et al., 2007). This is compensated for by bending magnets which have higher magnetic fields and larger bending radii. Moreover, the reduced lateral scattering and increased magnetic rigidity of high-energy ions lead to a very long BDS of typically 6m to 10m (for","PeriodicalId":91344,"journal":{"name":"Journal of the ICRU","volume":"67 1","pages":"37 - 58"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"3. Beam Delivery and Properties\",\"authors\":\"\",\"doi\":\"10.1093/jicru_ndy026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"With the exception of the first ion beam treatments using deuterium and helium beams in 1954 at Berkeley, which were cyclotron-based, only synchrotron-based therapy facilities are in operation today for carbon or other light ion beam therapy. This is due to the significantly higher energies needed to achieve the same range as a proton beam. After the early studies at the Lawrence Berkeley National Laboratory (LBNL) (Castro, 1993), all dedicated particle therapy facilities concentrated primarily on carbon beams for radiotherapy. The layout of a modern synchrotron for carbon ions is also suited to accelerate protons and many therapy facilities do offer proton beams for therapy in addition to carbon ions, which facilitates comparative clinical trials between modalities. Although technically feasible, only the Heidelberg ion beam facility (Haberer et al., 2004) is offering the possibility of providing helium and oxygen ions in addition to protons and carbon ions in all treatment rooms for potential future clinical use. The magnet strength and the fixed diameter of the accelerator ring limit the maximum achievable energy for each ion. A typical synchrotron-based ion facility comprises the following main components: (i) one or several ion sources; (ii) a linac, which acts as a pre-accelerator; (iii) the main synchrotron accelerator to produce high-energy ions; (iv) a beam-transport system to steer the beam to the treatment-delivery system; (v) a treatment-delivery system to adapt the individual treatment fields for each patient. Ion sources use an ionized gas to produce the ions, so that only specific ions can be extracted, using a spectrometer, to select a well-defined charge to mass ratio. The ionized gas is confined by magnetic fields and heated by microwaves, so that a plasma is created. Therefore, separate ion sources are in use for protons, carbon and helium ions, while an oxygen beam can be extracted from the same source as carbon (using carbon dioxide). The beam from different ion sources can be switched quickly to the injection beam line, using a switching magnet. The extraction of a different ion from the same source takes time to tune the source. The ion source is also used to control the beam intensity. The linac injector accelerates ions from several keV/u to the injection energy of the synchrotron, which is typically around 5MeV/u to 10MeV/u. In the main ring, bunches of ions are being injected, accelerated step by step to the desired energy and then extracted to the high-energy beam transport system. This means that the extracted energy can be adapted according to the energy requested by a treatment plan. During acceleration, the magnetic field strength in the ring magnets has to be gradually increased, as well as the frequency of the accelerating radio frequency (RF) cavity. The setting of all the beam elements from the ion source to the high-energy beam line is controlled by an accelerator control system (ACS). The ACS usually can provide predefined sets of ion type, energy, beam diameter, and beam intensity. In the beam delivery system (BDS), the small focused mono-energetic beam is modified, such that a useful treatment field is formed. Moreover, it is monitoring the delivered beam and has control over the delivered RBE-weighted dose to the patient. The BDS may use passive or dynamic techniques and is controlled by the treatment control system (TCS), which also has control over the ACS. The TCS also serves as an interface to the treatmentplanning system. In view of the safety of the patient, the TCS is the most important system in the facility. The BDS may furthermore comprise some or all of the following subsystems: nozzle, monitoring system, beam scanner, gating device, patient positioning and immobilization system. In practice, carbon energies of 400MeV/u (i.e., total kinetic energies of 4.8 GeV) are required to penetrate 25 cm in water (Chu et al., 1993). The higher energy of the extracted ions as compared to a proton therapy beam leads to an increased magnetic rigidity of the beam (Trbojevic et al., 2007). This is compensated for by bending magnets which have higher magnetic fields and larger bending radii. Moreover, the reduced lateral scattering and increased magnetic rigidity of high-energy ions lead to a very long BDS of typically 6m to 10m (for\",\"PeriodicalId\":91344,\"journal\":{\"name\":\"Journal of the ICRU\",\"volume\":\"67 1\",\"pages\":\"37 - 58\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the ICRU\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/jicru_ndy026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the ICRU","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jicru_ndy026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

除了1954年在伯克利使用氘和氦束进行的第一次离子束治疗,这是基于回旋加速器的,今天只有基于同步加速器的治疗设施在运行,用于碳或其他光离子束治疗。这是由于要达到与质子束相同的距离需要更高的能量。在劳伦斯伯克利国家实验室(LBNL) (Castro, 1993)的早期研究之后,所有专门的粒子治疗设施主要集中在碳束放射治疗上。现代碳离子同步加速器的布局也适合于加速质子,许多治疗设施除了提供碳离子治疗外,还提供质子束,这有助于不同模式之间的比较临床试验。虽然技术上可行,但只有海德堡离子束设施(Haberer et al., 2004)提供了在所有治疗室提供质子和碳离子之外的氦和氧离子的可能性,以供未来潜在的临床使用。磁铁的强度和加速器环的固定直径限制了每个离子可达到的最大能量。一个典型的基于同步加速器的离子设施包括以下主要组成部分:(i)一个或几个离子源;(ii)作为预加速器的直线加速器;(三)主同步加速器产生高能离子;(iv)光束传输系统,将光束引导至治疗输送系统;(v)为每个病人调整个别治疗领域的治疗递送系统。离子源使用电离气体来产生离子,因此只有特定的离子才能被提取出来,使用光谱仪来选择一个明确的电荷质量比。电离后的气体受到磁场的限制,并被微波加热,这样就产生了等离子体。因此,质子、碳离子和氦离子使用不同的离子源,而氧束可以从与碳相同的来源(使用二氧化碳)中提取。来自不同离子源的光束可以使用开关磁铁快速切换到注入束流线上。从同一源提取不同的离子需要时间来调整源。离子源也用于控制光束强度。直线注入器将数keV/u的离子加速到同步加速器的注入能量,通常在5MeV/u至10MeV/u左右。在主环中,离子束被注入,逐步加速到所需的能量,然后被提取到高能束流传输系统。这意味着提取的能量可以根据治疗计划所需的能量进行调整。在加速过程中,环形磁体中的磁场强度必须逐渐增加,加速射频(RF)腔的频率也必须逐渐增加。从离子源到高能束流线的所有束流元素的设置由加速器控制系统(ACS)控制。ACS通常可以提供预先设定的离子类型、能量、束流直径和束流强度。在光束输送系统(BDS)中,对小聚焦单能量光束进行修饰,从而形成有用的治疗场。此外,它正在监测输送的光束,并控制输送给患者的rbe加权剂量。北斗系统可以采用被动或动态技术,由处理控制系统(TCS)控制,该系统也可以控制ACS。TCS还作为治疗计划系统的接口。考虑到病人的安全,TCS是医院中最重要的系统。北斗系统还可能包括以下部分或全部子系统:喷嘴、监测系统、波束扫描仪、门控装置、患者定位和固定系统。实际上,在水中穿透25厘米需要400MeV/u的碳能量(即总动能为4.8 GeV) (Chu et al., 1993)。与质子治疗束相比,提取的离子能量更高,导致束的磁刚性增加(Trbojevic等人,2007)。这是由具有更高磁场和更大弯曲半径的弯曲磁铁补偿的。此外,减少的横向散射和增加的高能离子的磁刚性导致了非常长的BDS,通常为6米至10米
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
3. Beam Delivery and Properties
With the exception of the first ion beam treatments using deuterium and helium beams in 1954 at Berkeley, which were cyclotron-based, only synchrotron-based therapy facilities are in operation today for carbon or other light ion beam therapy. This is due to the significantly higher energies needed to achieve the same range as a proton beam. After the early studies at the Lawrence Berkeley National Laboratory (LBNL) (Castro, 1993), all dedicated particle therapy facilities concentrated primarily on carbon beams for radiotherapy. The layout of a modern synchrotron for carbon ions is also suited to accelerate protons and many therapy facilities do offer proton beams for therapy in addition to carbon ions, which facilitates comparative clinical trials between modalities. Although technically feasible, only the Heidelberg ion beam facility (Haberer et al., 2004) is offering the possibility of providing helium and oxygen ions in addition to protons and carbon ions in all treatment rooms for potential future clinical use. The magnet strength and the fixed diameter of the accelerator ring limit the maximum achievable energy for each ion. A typical synchrotron-based ion facility comprises the following main components: (i) one or several ion sources; (ii) a linac, which acts as a pre-accelerator; (iii) the main synchrotron accelerator to produce high-energy ions; (iv) a beam-transport system to steer the beam to the treatment-delivery system; (v) a treatment-delivery system to adapt the individual treatment fields for each patient. Ion sources use an ionized gas to produce the ions, so that only specific ions can be extracted, using a spectrometer, to select a well-defined charge to mass ratio. The ionized gas is confined by magnetic fields and heated by microwaves, so that a plasma is created. Therefore, separate ion sources are in use for protons, carbon and helium ions, while an oxygen beam can be extracted from the same source as carbon (using carbon dioxide). The beam from different ion sources can be switched quickly to the injection beam line, using a switching magnet. The extraction of a different ion from the same source takes time to tune the source. The ion source is also used to control the beam intensity. The linac injector accelerates ions from several keV/u to the injection energy of the synchrotron, which is typically around 5MeV/u to 10MeV/u. In the main ring, bunches of ions are being injected, accelerated step by step to the desired energy and then extracted to the high-energy beam transport system. This means that the extracted energy can be adapted according to the energy requested by a treatment plan. During acceleration, the magnetic field strength in the ring magnets has to be gradually increased, as well as the frequency of the accelerating radio frequency (RF) cavity. The setting of all the beam elements from the ion source to the high-energy beam line is controlled by an accelerator control system (ACS). The ACS usually can provide predefined sets of ion type, energy, beam diameter, and beam intensity. In the beam delivery system (BDS), the small focused mono-energetic beam is modified, such that a useful treatment field is formed. Moreover, it is monitoring the delivered beam and has control over the delivered RBE-weighted dose to the patient. The BDS may use passive or dynamic techniques and is controlled by the treatment control system (TCS), which also has control over the ACS. The TCS also serves as an interface to the treatmentplanning system. In view of the safety of the patient, the TCS is the most important system in the facility. The BDS may furthermore comprise some or all of the following subsystems: nozzle, monitoring system, beam scanner, gating device, patient positioning and immobilization system. In practice, carbon energies of 400MeV/u (i.e., total kinetic energies of 4.8 GeV) are required to penetrate 25 cm in water (Chu et al., 1993). The higher energy of the extracted ions as compared to a proton therapy beam leads to an increased magnetic rigidity of the beam (Trbojevic et al., 2007). This is compensated for by bending magnets which have higher magnetic fields and larger bending radii. Moreover, the reduced lateral scattering and increased magnetic rigidity of high-energy ions lead to a very long BDS of typically 6m to 10m (for
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ICRU Report 98, Stochastic Nature of Radiation Interactions: Microdosimetry ICRU REPORT 97: MRI-Guided Radiation Therapy Using MRI-Linear Accelerators Dosimetry-Guided Radiopharmaceutical Therapy Glossary of Terms and Definitions of Basic Quantities 5 Practical Consequences of the Introduction of the Recommended Operational Quantities
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1